Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
Disease Category: Acute Myelogenous Leukemia (AML)

Trial Information

CIBMRT 05-DCB: A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy

You have been asked to participate in this research study because you have acute leukemia or myelodysplastic syndrome (cancer of the blood and/or bone marrow) that is at high risk of returning.  The main purpose of this research is to find out how good a cord blood transplant using two cord blood units is in terms of the number of subjects who survive one year after transplant.  Your treatment on this study is expected to last several months.  After your treatment on this study is over, your medical condition will continue to be followed until at least two years after your transplant.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.